Website Logo
Board of Directors

Christopher Whitfield is the Chief Executive Officer of Batswadi Pharmaceuticals, a black empowered company launched last year with a view to leveraging the unmet needs of the South African pharmaceutical market, and focused on the biotechnology sector.

Batswadi (the Tswana word for "parent") aims to increase Africa's access to innovative products, diagnostics, devices, and services.

Prior to this, Mr Whitfield was General Manager of multinational pharmaceutical manufacturer Eli Lilly.

Daniel Du Toit is Professor and Head of the Department of Biomedical Sciences at the Faculty of Science, Tshwane University of Technology, a position he has held since 1997. Over the past seven years, Prof Du Toit has been appointed to various committees by the Minister of Health, and is currently the chairperson of the Medical Research Council (MRC) Ethics Committee as well as chairperson of the National Health Research Ethics Council of SA.

Prof Du Toit holds a doctorate in physiology, has published over 40 papers in national and international accredited journals, and has presented more than 150 papers both locally and overseas.


Arthur graduated with a BCom LLB from the University of Cape Town in 1992 before traveling extensively overseas for several years. His passion for Investments was initially ignited through working at Nomura International in London. Upon his return to SA, he joined Commercial Union which was later bought by Metropolitan. Over this period, Arthur was awarded his CFA Charter.

Arthur worked for Metropolitan Asset Managers as an Analyst and Portfolio Manager from 1999 to 2006. As an Analyst his primary responsibilities were in the Industrial Sector by covering several subsectors. During his tenure at Metropolitan as a Portfolio Manager he was responsible for third party funds, the Resource Unit Trust, Metropolitan's SADC funds, the biggest of which was from Namibia, and the Metropolitan Small Cap Fund.

He left Metropolitan in 2006 to gain experience in Hedge Fund Management, initially joining Breakwater Capital as Co-Manager of the Impact Fund and then Trilinear Asset Management as head of research and a portfolio manager. Currently he is a director and CIO at 3 Laws Capital, which has a Climate Change Fund, a Private Equity Fund and an Impact Fund.